Zurich Cantonal Bank’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Zurich Cantonal Bank’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,135	Closed	-$32.5K	–	2868
2023 Q1	$32.5K	Buy	+12,135	New	+$58.3K	﹤0.01%	2685
2022 Q2	–	Sell	-5,118	Closed	-$39K	–	2944
2022 Q1	$39K	Hold	5,118	–	–	﹤0.01%	2580
2021 Q4	$52K	Hold	5,118	–	–	﹤0.01%	2727
2021 Q3	$69K	Hold	5,118	–	–	﹤0.01%	2513
2021 Q2	$112K	Hold	5,118	–	–	﹤0.01%	2162
2021 Q1	$123K	Hold	5,118	–	–	﹤0.01%	2046
2020 Q4	$92K	Buy	5,118 +2,278	+80%	+$34K	﹤0.01%	2248
2020 Q3	$33K	Hold	2,840	–	–	﹤0.01%	2375
2020 Q2	$69K	Buy	2,840 +1,741	+158%	+$28.8K	﹤0.01%	2111
2020 Q1	$12K	Hold	1,099	–	–	﹤0.01%	2448
2019 Q4	$29K	Hold	1,099	–	–	﹤0.01%	2399
2019 Q3	$25K	Hold	1,099	–	–	﹤0.01%	2391
2019 Q2	$34K	Hold	1,099	–	–	﹤0.01%	2275
2019 Q1	$18K	Hold	1,099	–	–	﹤0.01%	2445
2018 Q4	$21K	Buy	1,099 +631	+135%	+$23.6K	﹤0.01%	2437
2018 Q3	$24K	Buy	+468	New	+$25.5K	﹤0.01%	2446

Other funds holding GTHX

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zurich Cantonal Bank's GTHX Position: Q2 2023 in Review

Zurich Cantonal Bank sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2023, closing a stake of 12,135 shares — an estimated $32.5K sold.

Zurich Cantonal Bank first reported a position in GTHX in Q3 2018 and held it in 16 quarters. The position peaked at $123K in Q1 2021. 80 funds tracked by Wall St. Rank hold GTHX as of Q2 2023.

Zurich Cantonal Bank reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Zurich Cantonal Bank sold 12,135 G1 Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $32.5K.
Zurich Cantonal Bank first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2018 and held it in 16 quarters.
Zurich Cantonal Bank's G1 Therapeutics, Inc. Common Stock position peaked at $123K in Q1 2021.
80 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Zurich Cantonal Bank's 13F filing for Q2 2023, filed 7 Aug 2023.